Duke Health Sector Advisory Council

Marion Everett Couch, MD, PhD, MBA

Marion Everett Couch, MD, PhD, MBA


Intovalue LLC

Marion brings a unique perspective to improving health care. Currently, Marion serves as CEO at Intovalue LLC, a company committed to helping employers and medical groups move towards paying for value in healthcare. Prior to this role, she was the Senior Vice President of Health Care Services and the Chief Medical Officer at Cambia Health Solutions which administers the Regence Blue Cross Blue Shield (BCBS) health insurance plans that span four states and serves 3.1 million members. She led medical strategy for all of Cambia and provided executive operational leadership for all the Regence BCBS plans.

Prior to this role, Marion was the Senior Medical Advisor (career) in the Office of the Administrator at the CMS in Washington, DC. She reported directly to the Administrator to work on policy creation, improvements in quality programs, and national coverage decisions. Marion was also involved in developing value-based payment models in the Center for Medicare and Medicaid Innovation (CMMI).

She began her career as a faculty member at Johns Hopkins Hospital. Marion has previously served as the Chair of the Board for a large academic medical group practice. She has been a physician executive in two large medical groups, the Chair of two surgical departments, Surgeon-in-Chief at an academic medical center, and President of two national professional medical societies. Marion is a trained surgeon who completed her residency training was at Johns Hopkins Hospital. Her MBA degree is from the Duke University Fuqua Business School. She is currently an Adjunct Professor in the Duke University School of Medicine.

Elisabeth DelGrosso, MBA

Vice President, Strategy, Partnerships & Product


Elisabeth DelGrosso leads Strategy and Product for CareAllies, a Cigna company that focuses on helping providers on their journey to Value-Based Care (VBC) across all health plan lines of business. In this role, she has oversight for overall strategic direction and Enterprise partnerships for all CareAllies business areas as well as the packaging and positioning of its client service offerings. Elisabeth joined CareAllies in 2017 shortly after it was founded and has been instrumental in shaping the organization into its current state and future direction, particularly leading alignment of its strategy with Cigna Enterprise needs, provider client-facing strategic initiatives such as formation of strategic alliances and joint ventures, as well the build out of key functions and corresponding teams to create organizational strategy and operational readiness for growth.

Prior to joining CareAllies, Elisabeth served as Chief of Staff to the President of the Client Organization at athenahealth during its post-IPO rapid growth period. As Chief of Staff, she led the internal strategy, planning, and management of that growth for the client-facing division that encompassed sales, account management, customer support, and implementations. She began her career in strategy consulting for providers, primarily focused on national and regional mergers and acquisitions, affiliation partnerships, strategic planning, and physician-hospital alignment.

Elisabeth holds a Master’s degree in business administration with a focus on Strategy and Health Sector Management (HSM) from Duke University and a Bachelors of Arts degree in Public Health Studies from Johns Hopkins University. She lives in the greater Princeton area of New Jersey and is a Duke-UNC house divided with her husband, who is a Tar Heel, and two young sons, who she plans to be Duke fans!

Jeremy Petranka, PhD

Senior Associate Dean for Executive MBA and Quantitative Management Programs and Associate Professor of the Practice

Fuqua School of Business

Dr. Jeremy Petranka is the Senior Associate Dean for Executive MBA and Quantitative Management Programs and an Associate Professor of the Practice in the Fuqua School of Business. He received his Ph.D. in Economics from UNC Chapel Hill in 2009, and has since taught undergraduates and MBA students at Indiana University’s Kelley School of Business and UNC Chapel Hill.

Prior to his career in academia, Jeremy worked as a management consultant, working with multiple Fortune 100 companies to align their information technology with their business strategies, focusing heavily on the role of data within the organizations. His work now focuses on the intersection of business and academics, specifically targeting how economics informs managerial decision-making and business strategy.

Bill Boulding, PhD

Dean and J.B. Fuqua Professor of Business

The Fuqua School of Business

Bill Boulding, PhD is the JB Fuqua Professor of Business Administration and Deputy Dean at The Fuqua School of Business, Duke University. William “Bill” Boulding is an accomplished scholar with a passion for helping advance business as a force for good.

Bill has advocated at the top levels of government, industry and academia for ways that enable business to improve society. In 2014, Bill was invited by the White House to be part of an initiative that developed best practices for how business schools can encourage success for women and working families. In 2015, Bill engaged with the New York Federal Reserve in examining the role business schools can play in rebuilding trust in the financial services sector.

Bill’s passionate belief in creating future business leaders who have the ability to bring people who are very different together to work toward a common goal, led to the school’s number-one ranking by Bloomberg Businessweek in 2014. Bill is a sought-after expert by the media on leadership trends and the qualities needed to succeed today, and has been interviewed by CNBC, Bloomberg, The Wall Street Journal and the Financial Times, among others. Bill shares his insights regularly on LinkedIn , and was named a Top Voice on the platform in 2016. He also writes for Fortune and Harvard Business Review.

Bill serves as a member of the World Economic Forum’s Council on Values and chairs the board of the Graduate Management Admission Council (GMAC®), which is the organization that administers the GMAT exam. He is chair of the Board of Directors of Duke Corporate Education and serves on Swarthmore College’s Board of Managers.

Bill has engaged in sponsored research, consulting, or executive development with a number of companies such as IBM, AT&T, Bank of America, Sears, Eli Lilly, Blue Cross/Blue Shield, Ford Motor Company, Lafarge, US Postal Service, Stride Rite, Wolseley, Hanes, Harnischfeger, Thomson Newspapers, Siemens, and Citibank.

Bill has a research interest in evaluating how managers make decisions and how consumers respond. His recent work focuses on the domain of health care, examining the role of the patient experience, clinical adherence to standards and managerial activity in determining the quality of delivered care. His work has been widely published in a number of journals and Bill has been the recipient of numerous research and teaching awards. You can learn more about his research here.

Bill received his BA in Economics from Swarthmore College and his PhD in Managerial Sciences and Applied Economics from the Wharton School, University of Pennsylvania.

Mark McClellan, MD, PhD

Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy


Mark McClellan, MD, PhD is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University.

McClellan is a physician and an economist who has informed and improved a wide range of strategies and policy reforms to advance health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation. Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership.

With highly distinguished record in public service and academic research, McClellan is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These reforms include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care. He previously served as a member of the President’s Council of Economic Advisers, senior director for health care policy at the White House, and Deputy Assistant Secretary for Economic Policy at the Department of the Treasury.

McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the FDA and a member of the National Academy of Medicine (NAM), where he chairs the Leadership Council for Value and Science-Driven Health care, co-chairs the guiding committee of the Health Care Payment Learning and Action Network, and is a research associate at the National Bureau of Economic Research. He is also a Senior Advisor on the faculty of the University of Texas Dell Medical School, co-chair of the Accountable Care Learning Collaborative, and a member of the Healthtech 4 Medicaid Board of Directors. McClellan is also an independent director on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and Seer. He was previously an associate professor of economics and medicine with tenure at Stanford University, and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.

David Ridley, PhD

Faculty Director

Duke Health Sector Management

David Ridley, PhD is the Dr. and Mrs. Frank A. Riddick Professor of the Practice of Business. He is also the Faculty Director of Duke’s Health Sector Management. Ridley teaches in the daytime MBA, executive MBA, and Health Analytics programs. He received a PhD in economics from Duke University in 2001.

In his research, Ridley examines innovation and pricing in health care. To encourage development of new treatments for neglected diseases, Ridley (with Jeff Moe and Henry Grabowski) proposed the priority review voucher program which became law in the United States in 2007. Total voucher sales have exceeded one billion dollars. Ridley’s research appears in economics journals (Journal of Public Economics), medical journals (Journal of the American Medical Association), and scientific journals (Nature Reviews Drug Discovery).